Form 4 for EQH Equitable Holdings, Inc.
Accepted 2025-07-16 00:00:00 ET · period of report 2025-07-15 · accession 0001628280-25-035101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-16 | 2025-07-15 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $52.22 | -30.0K | 714.6K | -4% | -$1.57M |
| D | 2025-07-16 | 2025-07-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $23.18 | +20.0K | 744.4K | +3% | +$463.6K |
| D | 2025-07-16 | 2025-07-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 326.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-15 | S | D | 200 | $53.12 | 714,367.21 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F6) This transaction was executed at a price of $53.1200, therefore only a single price is reported. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was affected. (F2) Includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2025-07-15 | S | D | 300 | $53.05 | 724,367.21 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F4) This transaction was executed in multiple trades at prices ranging from $52.9500 to $53.1000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. (F2) Includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2025-07-15 | S | D | 19,700 | $52.20 | 724,667.21 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F3) This transaction was executed in multiple trades at prices ranging from $51.8600 to $52.7800. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. (F2) Includes Restricted Stock Units. |
| 4 | Common | Common Stock | 2025-07-15 | M | A | 20,000 | $23.18 | 744,367.21 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F2) Includes Restricted Stock Units. |
| 5 | Common | Common Stock | 2025-07-15 | S | D | 9,800 | $52.21 | 714,567.21 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F5) This transaction was executed in multiple trades at prices ranging from $51.8600 to $52.6400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. (F2) Includes Restricted Stock Units. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-07-15 | M | D | 20,000 | $0.00 | 326,400 | D | $23.18 · — to 2030-02-26 | 20,000 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F7) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021. |